BioSpace News Archive

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Targovax and Leidos will jointly explore the potential of combining their ONCOS and MicrotideTM technology platforms

Yuva Biosciences, an anti-aging startup based on technology developed by one of the world leaders in mitochondrial sciences, Dr. Keshav K. Singh, is pleased to announce that Dr. Singh joined the Science of AgingSM faculty, a platform owned and run by Allergan Aesthetics Medicine R&D.

Targeting a Phase 2b psychedelic assisted therapy trial for the treatment of anxiety disorders

Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased to announce the closing of a Series B equity financing of $26 million.

Annual Awards Program Honors Outstanding Health & Medical Technology Products and Companies for their excellence, creativity, hard work and success

Silverback Therapeutics (“Silverback”), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered, but locally active, today announced the appointment of Vickie L. Capps as director and audit committee chair. “Vickie has had a distinguished career in finance and executive leadership, and I was fortunate to have her guidance on the board of Synthorx,” said Laura Shawver, Ph.D., president, c

Celerion announced today the multimillion-dollar expansion of specialized pharmacies across their clinical research units in North America, demonstrating their commitment to further assisting sponsors in meeting the forthcoming USP requirements for compounding investigational drug product in support of early phase clinical trial research.

First presentation of Alpine’s Variant Tumor Necrosis Factor (TNF) Receptor Domain (vTD) Program demonstrating expanded applicability of its directed evolution platform

Streamline Health Solutions, Inc. (NASDAQ:STRM), provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises today announced that it will release its first quarter 2020 financial performance for the period that ended April 30, 2020, on Wednesday, June 10, 2020 after the close of the financial markets. The Company will conduct a conference call to review the resu